A4i-O: A Platform for Complex Behavioral Health to Address OUD
Key facts
- Who runs it
- Centre for Addiction and Mental Health
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 14 people enrolled
- Started
- 5 Feb 2024
- Ended
- 1 Nov 2024
- Type of study
- Interventional
- Treatments tested
- App for Independence-O (A4i-O)
- Record updated
- 22 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Participants will be adults, 18 years of age or older, with a provider-assigned diagnosis of OUD confirmed by the SCID-5. Electronic medical records will be accessed for CAMH clients after informed consent is obtained to confirm the OUD diagnosis. For clients who were recruited externally and do not have a CAMH chart, confirmation of diagnosis will be sought from the referring clinician
- All participants will be engaged in outpatient psychiatric treatment for OUD
- All participants will currently be engaged in opioid agonist treatment
- Proficiency in English via ability to understand written/verbal communication during consent process. Any RA concerns about ability to understand English will be brought to the PI for determination of next steps (see consent procedures below)
- Own and use an Android or iOS smartphone
- All participants will be open to having their care provider participate in the study
Who cannot take part
- Lack of capacity to consent
- Intellectual disability
- Experiencing distress at a level that would affect research and technology engagement (e.g., acute suicidality); Criteria (service providers): Service providers will be psychiatrists and case managers engaged in the care of the participants
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
For the purposes of beta testing the first version of A4i-O, 15 individuals with OUD will use the platform for one month. From a design perspective this sample size is viewed as being sufficient to answer questions regarding app functionality and feasibility before moving to larger trials. Additionally, 15 individuals is a larger sample size than in the A4i pilot. This is an open label pilot with a primary objective of troubleshooting and providing early feedback on the beta version of the technology. To that end, 15 participants are anticipated to be sufficient to provide robust, early feedback. As with the focus groups, through sampling an effort will be made to secure a diverse group. Any individuals who might be declined in that effort at this stage (e.g., it is determined that no more male identifying participants are needed but they were interested) would be invited to take part in the subsequent RCT.
The group in the trial
- App for Independence-O (A4i-O)Treatment being tested
Participants will be provided with A4i-O for one month.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- App for Independence-O (A4i-O) - Expanding a Validated Platform for Complex Behavioral Health to Address Opioid Use Disorder
- Record updated
- 22 April 2026